Zacks Research Has Positive Estimate for MMSI Q1 Earnings

Key Points

• Zacks Research raised its Q1 2027 EPS estimate for Merit Medical Systems to $0.88 from $0.84; analysts expect full-year earnings of $3.81 per share.
• Merit Medical recently exceeded quarterly expectations, reporting $1.19 EPS versus the $0.96 consensus and revenue of $418.84 million, up 9.5% year over year.
• Analyst sentiment remains favorable, with eight Buy ratings and four Holds, producing a “Moderate Buy” consensus and an average price target of $100.00.

Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) - Research analysts at Zacks Research lifted their Q1 2027 earnings estimates for shares of Merit Medical Systems in a research report issued on Thursday, August 20th. Zacks Research analyst Team now anticipates that the medical instruments supplier will post earnings of $0.88 per share for the quarter, up from their previous estimate of $0.84. The consensus estimate for Merit Medical Systems' current full-year earnings is $3.81 per share. Zacks Research also issued estimates for Merit Medical Systems' Q4 2027 earnings at $1.10 EPS.

MMSI has been the subject of a number of other reports. Raymond James Financial reiterated an "outperform" rating and issued a $100.00 price target on shares of Merit Medical Systems in a report on Friday, July 31st. Needham & Company LLC lifted their price objective on shares of Merit Medical Systems from $90.00 to $101.00 and gave the stock a "buy" rating in a report on Friday, July 31st. Weiss Ratings upgraded shares of Merit Medical Systems from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, August 18th. Wells Fargo & Company increased their target price on shares of Merit Medical Systems from $74.00 to $83.00 and gave the stock an "equal weight" rating in a report on Friday, July 31st. Finally, Robert W. Baird set a $98.00 price target on shares of Merit Medical Systems in a report on Friday, July 31st. Eight investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $100.00.

Merit Medical Systems Stock Performance

NASDAQ:MMSI opened at $90.78 on Monday. The company has a quick ratio of 2.79, a current ratio of 4.20 and a debt-to-equity ratio of 0.44. The business's 50 day moving average is $77.41 and its two-hundred day moving average is $72.51. Merit Medical Systems has a 52 week low of $59.74 and a 52 week high of $94.75. The company has a market cap of $5.42 billion, a PE ratio of 37.51, a P/E/G ratio of 2.28 and a beta of 0.48.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, topping the consensus estimate of $0.96 by $0.23. The business had revenue of $418.84 million for the quarter, compared to analysts' expectations of $405.25 million. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The company's quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter last year, the company posted $1.01 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in MMSI. Kilter Group LLC bought a new stake in Merit Medical Systems in the second quarter valued at $25,000. Los Angeles Capital Management LLC bought a new position in shares of Merit Medical Systems during the fourth quarter worth about $25,000. Torren Management LLC bought a new position in shares of Merit Medical Systems during the fourth quarter worth about $38,000. Covestor Ltd increased its holdings in shares of Merit Medical Systems by 252.6% in the 4th quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier's stock worth $41,000 after acquiring an additional 336 shares during the period. Finally, Danske Bank A S acquired a new stake in shares of Merit Medical Systems in the 3rd quarter worth about $42,000. 99.66% of the stock is currently owned by institutional investors.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company's product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source